Drug intelligence / Profile preview

inositol + alpha-lactalbumin

Development stage
Unknown
Lead developer
Ego Pharmaceuticals
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral
01

Overview

A combination of **inositol** (specifically myo-inositol) and **alpha-lactalbumin** is an oral formulation primarily investigated as a dietary supplement for **improving insulin resistance and reproductive/metabolic disturbances in women with polycystic ovary syndrome (PCOS)**, as well as **reducing insulin resistance and excessive fetal growth in gestational diabetes mellitus (GDM)**[1][3][4][5]. - Myo-inositol is a carbocyclic sugar involved in cellular signaling and metabolic regulation, known to improve insulin sensitivity and ovarian function. - Alpha-lactalbumin is a major whey protein in mammalian milk that not only serves as a nutrient but also aids intestinal absorption of myo-inositol, increases its plasma bioavailability, and may exert anti-inflammatory effects by inhibiting cyclooxygenase-2 (COX2) and decreasing IL-6 levels[4][5]. - In clinical studies, the combination was shown to restore ovulation in myo-inositol-resistant PCOS patients and reduce the need for insulin treatment and pre-term birth rates in GDM[1][3][4][5]. - The combination may also modulate gut microbiota, enhancing myo-inositol absorption[4][5].

Other names
myo-inositol + alpha-lactalbumin
02

Targets

IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)INSR (Insulin receptor)

Beyond the preview

Go deeper on inositol + alpha-lactalbumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on inositol + alpha-lactalbumin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call